Zheng, M., Hu, Y., Gou, R., Liu, O., Nie, X., Li, X., . . . Lin, B. (2020). Identification of immune‐enhanced molecular subtype associated with BRCA1 mutations, immune checkpoints and clinical outcome in ovarian carcinoma. J Cell Mol Med.
Dyfyniad Arddull ChicagoZheng, Mingjun, et al. "Identification of Immune‐enhanced Molecular Subtype Associated With BRCA1 Mutations, Immune Checkpoints and Clinical Outcome in Ovarian Carcinoma." J Cell Mol Med 2020.
Dyfyniad MLAZheng, Mingjun, et al. "Identification of Immune‐enhanced Molecular Subtype Associated With BRCA1 Mutations, Immune Checkpoints and Clinical Outcome in Ovarian Carcinoma." J Cell Mol Med 2020.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.